Xenon Pharmaceuticals Inc. XENE
- XEN1120 — Acute Pain Phase 1
- azetukalner — Focal Onset Seizures Phase 3
- azetukalner — Major Depressive Disorder Phase 3
- azetukalner — Bipolar Depression Phase 3
Kv7 (1 companies · 4 programs)
Companies with an active program directed at Kv7.